Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Discovery and Validation of Genetic Variants Affecting Microglial Activation in Alzheimer's Disease With 11C-ER176

NCT04840979 is registered in ClinicalTrials.gov with Columbia University as lead sponsor.

NCT NCT04840979
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04840979 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Discovery and Validation of Genetic Variants Affecting Microglial Activation in Alzheimer's Disease With 11C-ER176
Lead sponsor
Columbia University
Phase
Phase 2
Overall status
Active, not recruiting
Start date
May 11, 2021
Completion date
December 31, 2026
Enrollment
107 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease